What is the heparin‑induced thrombocytopenia (HIT) panel and what laboratory order should be placed for a patient receiving heparin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

HIT Panel and Laboratory Ordering

For a patient on heparin with suspected HIT, order an anti-PF4 (platelet factor 4) antibody immunoassay as the first-line laboratory test, but only if the clinical probability is intermediate or high based on the 4T score. 1

Clinical Assessment First: The 4T Score

Before ordering any laboratory tests, calculate the 4T score to determine pre-test probability 1:

  • Thrombocytopenia: Degree and timing of platelet fall
  • Timing: Onset 5-10 days after heparin start (or within 24 hours if prior heparin exposure in past 30-100 days)
  • Thrombosis: New thrombosis or other sequelae
  • Other causes: Alternative explanations for thrombocytopenia

Score interpretation 1:

  • 0-3: Low probability
  • 4-5: Intermediate probability
  • 6-8: High probability

Laboratory Testing Algorithm

If 4T Score is Low (≤3):

  • Do NOT order HIT testing 1
  • Continue heparin if indicated
  • Search for alternative causes of thrombocytopenia
  • Monitor platelet counts closely

If 4T Score is Intermediate (4-5) or High (≥6):

Order anti-PF4 antibody immunoassay immediately 1

The "HIT panel" consists of:

  1. First-line test: Anti-PF4 antibody immunoassay (immunological test)

    • IgG-specific enzyme immunoassays (EIAs) preferred for better specificity 2
    • Newer rapid assays include chemiluminescence immunoassay (CLIA) or latex immunoturbidimetric assay (LIA) 2
    • High sensitivity (~95%) but variable specificity 2
  2. Second-line test (if anti-PF4 positive): Functional/platelet activation assay 1

    • Serotonin release assay (SRA) - considered "gold standard" with ~95% sensitivity and specificity 1, 2
    • Heparin-induced platelet activation (HIPA) test
    • Platelet aggregation test (PAT)
    • These confirm diagnosis by demonstrating platelet-activating antibodies 1

Critical Management Points

Do not wait for laboratory results to act 1. If the 4T score is intermediate or high:

  • Stop all heparin immediately (including heparin flushes) 1, 3
  • Start non-heparin anticoagulant at therapeutic doses before lab results return 1
  • Options include: argatroban, bivalirudin, danaparoid, fondaparinux, or direct oral anticoagulants 1

Interpretation of Results:

If anti-PF4 antibody test is negative with intermediate 4T score:

  • HIT excluded 1
  • Resume heparin if needed
  • Continue monitoring platelets

If anti-PF4 antibody test is positive:

  • Proceed to functional assay for confirmation 1
  • Continue non-heparin anticoagulation
  • If functional test positive: HIT confirmed 1

Common Pitfalls to Avoid

  • Don't order HIT testing on every patient with thrombocytopenia on heparin - this leads to false positives and unnecessary treatment with expensive, high-risk alternative anticoagulants 4, 5
  • Don't use the 4T score after cardiac surgery - it's not validated in this population 1
  • Don't forget that HIT can occur up to several weeks after stopping heparin 3
  • Monitor platelet counts before starting heparin and every 2-3 days during therapy (days 4-14 are highest risk) 3

Laboratory Order Specifics

Order name varies by institution, but typically:

  • "HIT antibody panel" or "Anti-PF4/heparin antibody" or "HIT immunoassay"
  • If positive, laboratory will typically reflex to functional assay automatically at reference labs 1

The immunoassay is performed first because functional assays (SRA, HIPA) are technically demanding, require specialized laboratories, and have longer turnaround times 1, 2.

References

Guideline

diagnosis and management of heparin-induced thrombocytopenia.

Anaesthesia Critical Care & Pain Medicine, 2020

Research

Laboratory diagnosis of heparin-induced thrombocytopenia.

International journal of laboratory hematology, 2019

Research

Practical guide to the diagnosis and management of heparin-induced thrombocytopenia.

Hematology. American Society of Hematology. Education Program, 2024

Research

Diagnosing heparin-induced thrombocytopenia: The need for accuracy and speed.

International journal of laboratory hematology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.